|
2021
|
Invention
|
Chimeric antigen receptors to her2 and methods of use thereof. The present disclosure provides ch... |
|
2019
|
Invention
|
Anti-ctla4 antibodies, antibody fragments, their immunoconjugates and uses thereof. A polypeptide... |
|
|
Invention
|
Conditionally active chimeric antigen receptors for modified t-cells. This disclosure relates to ... |
|
|
Invention
|
Conditionally active proteins with ph selectivity. A method of producing a conditionally active p... |
|
|
Invention
|
Multi-specific antibody constructs. A multi-specific antibody contains at least one binding site ... |
|
|
Invention
|
Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof. An anti-IL-22... |
|
2018
|
P/S
|
Therapeutic pharmaceutical for the treatment of age-related
diseases and cancer. Research and de... |
|
|
Invention
|
Multi-specific monoclonal antibodies.
The present invention is relevant to the generation of mul... |
|
|
Invention
|
Protein therapeutics for treatment of senescent cells. Methods of generating conditionally active... |
|
2017
|
Invention
|
Anti-cd22 antibodies.
Anti-CD22 antibodies, including isolated nucleic acids that encode at leas... |
|
|
Invention
|
Conditionally active polypeptides and methods of generating them. A method of preparing a conditi... |
|
|
Invention
|
Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof. A polypeptide ... |
|
|
Invention
|
Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof. A polypeptid... |
|
|
Invention
|
Diagnostics using conditionally active antibodies. A method of detecting tumor cells in a sample ... |
|
2016
|
Invention
|
Humanized anti-cd73 antibodies. Provided herein are, inter alia, humanized 1E9 antibodies capable... |
|
|
Invention
|
Conditionally active polypeptides. A non-naturally occurring polypeptide or isolated polypeptide ... |
|
|
Invention
|
Conditionally active proteins. Methods of generating conditionally active biologic proteins, in p... |
|
|
Invention
|
Conditionally active biological proteins. Methods of generating conditionally active biologic pro... |
|
|
Invention
|
Conditionally active chimeric antigen receptors for modified t-cells.
This disclosure relates to... |
|
2015
|
Invention
|
Discovering and producing conditionally active biologic proteins in the same eukaryotic cell prod... |
|
|
Invention
|
Conditionally active biological proteins. This disclosure relates to a method of generating condi... |
|
|
Invention
|
Proteins targeting orthologs. The present invention is relevant to polypeptides and novel methods... |
|
2013
|
Invention
|
Multi-specific monoclonal antibodies. The present invention is relevant to the generation of mult... |
|
|
Invention
|
Multi-specific monclonal antibodies. The present invention is relevant to the generation of multi... |
|
|
Invention
|
Modified antibody regions and uses thereof.
The present invention relates to modified Fc regions... |
|
|
Invention
|
Modified antibody regions and uses thereof. The present invention relates to modified Fc regions ... |
|
|
Invention
|
Anti-cd22 antibodies. Anti-CD22 antibodies, including isolated nucleic acids that encode at least... |
|
2011
|
Invention
|
Express humanization of antibodies. The disclosure provides a method for generation of humanized ... |
|
|
Invention
|
Comprehensive monoclonal antibody generation. The present invention relates to methods for effici... |
